IL2 and renal cell carcinoma: Received IL-2 for RCC with bone mets with CRRelapsed with bilateral adrenal metastases, 11 and 12.5 years after IL-2 therapy. Treated with local therapy, cryo therapy on one lesion and surgery on the other.